Deal overview

Deal overview
Target ALEXION PHARMACEUTICALS INC
Bidder ASTRAZENECA PLC
Price £110.00 Full version or £25.00 Light version
Publication Date Dec 12, 2020
Abstract On Saturday 12 December 2020, AstraZeneca plc ("AstraZeneca"), a UK-headquartered pharmaceuticals company, announced a recommended mixed cash and shares offer for the US-listed company Alexion Pharmaceuticals Inc ("Alexion"). The offer terms valued each Alexion share at $175.29 and 100% of Alexion's share capital at $39 billion. Alexion shareholders would own circa 15% of the ...
Number of pages (Full version) 11
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.036336s